NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|237649009|ref|NP_001153651|]
View 

arylamine N-acetyltransferase 1 isoform a [Homo sapiens]

Protein Classification

arylamine N-acetyltransferase( domain architecture ID 10466656)

arylamine N-acetyltransferase catalyzes the transfer of an acetyl group from acetyl coenzyme A (CoA) to the nitrogen or oxygen atom of a wide variety of aromatic amines (arylamines) and hydrazines

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
Acetyltransf_2 pfam00797
N-acetyltransferase; Arylamine N-acetyltransferase (NAT) is a cytosolic enzyme of ...
20-280 1.06e-125

N-acetyltransferase; Arylamine N-acetyltransferase (NAT) is a cytosolic enzyme of approximately 30kDa. It facilitates the transfer of an acetyl group from Acetyl Coenzyme A on to a wide range of arylamine, N-hydroxyarylamines and hydrazines. Acetylation of these compounds generally results in inactivation. NAT is found in many species from Mycobacteria (M. tuberculosis, M. smegmatis etc) to man. It was the first enzyme to be observed to have polymorphic activity amongst human individuals. NAT is responsible for the inactivation of Isoniazid (a drug used to treat Tuberculosis) in humans. The NAT protein has also been shown to be involved in the breakdown of folic acid.


:

Pssm-ID: 395644  Cd Length: 240  Bit Score: 357.74  E-value: 1.06e-125
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009   20 DLETLTDILQHQIRAVPFENLNIHCGDAMDLGLEAIFDQVVRRNRGGWCLQVNHLLYWALTTIGFETTMLGGYVYSTPAK 99
Cdd:pfam00797   1 DLETLRELHLHHLRAIPFENLDVHLGEPISLDLEALFDKLVHKRRGGYCYELNGLFYWVLTELGFDVTLLGGRVYWPRPG 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009  100 KYSTGMIHLLLQVTIDGRNYIVDAGFGRSYqMWQPLELISGKDQPQVPCVFRLTEENGF-WYLDQIRREQYIPneeflhs 178
Cdd:pfam00797  81 AYSTPQTHLLLLVTIDGETYLVDVGFGGST-LWAPLELISGKDQPTPHGIFRLVEEGGGtWYLEKDGRDGWVP------- 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009  179 dlledskyrkIYSFTLKPRTIEDFESMNTYLQTSPSSVFTSKSFCSLQTPDGVHCLVGFTLTHRrfnYKDNTdLIEFKTL 258
Cdd:pfam00797 153 ----------LYSFTLEPRQIEDFEVGNDYLQTSPDSHFTTHLLCSRQTPDGRLTLTGRTLTLR---YKDGA-LVEIRLL 218
                         250       260
                  ....*....|....*....|..
gi 237649009  259 SEEEIEKVLKNIFNISLQRKLV 280
Cdd:pfam00797 219 TDEEVEDVLKERFGIELDAKLV 240
 
Name Accession Description Interval E-value
Acetyltransf_2 pfam00797
N-acetyltransferase; Arylamine N-acetyltransferase (NAT) is a cytosolic enzyme of ...
20-280 1.06e-125

N-acetyltransferase; Arylamine N-acetyltransferase (NAT) is a cytosolic enzyme of approximately 30kDa. It facilitates the transfer of an acetyl group from Acetyl Coenzyme A on to a wide range of arylamine, N-hydroxyarylamines and hydrazines. Acetylation of these compounds generally results in inactivation. NAT is found in many species from Mycobacteria (M. tuberculosis, M. smegmatis etc) to man. It was the first enzyme to be observed to have polymorphic activity amongst human individuals. NAT is responsible for the inactivation of Isoniazid (a drug used to treat Tuberculosis) in humans. The NAT protein has also been shown to be involved in the breakdown of folic acid.


Pssm-ID: 395644  Cd Length: 240  Bit Score: 357.74  E-value: 1.06e-125
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009   20 DLETLTDILQHQIRAVPFENLNIHCGDAMDLGLEAIFDQVVRRNRGGWCLQVNHLLYWALTTIGFETTMLGGYVYSTPAK 99
Cdd:pfam00797   1 DLETLRELHLHHLRAIPFENLDVHLGEPISLDLEALFDKLVHKRRGGYCYELNGLFYWVLTELGFDVTLLGGRVYWPRPG 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009  100 KYSTGMIHLLLQVTIDGRNYIVDAGFGRSYqMWQPLELISGKDQPQVPCVFRLTEENGF-WYLDQIRREQYIPneeflhs 178
Cdd:pfam00797  81 AYSTPQTHLLLLVTIDGETYLVDVGFGGST-LWAPLELISGKDQPTPHGIFRLVEEGGGtWYLEKDGRDGWVP------- 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009  179 dlledskyrkIYSFTLKPRTIEDFESMNTYLQTSPSSVFTSKSFCSLQTPDGVHCLVGFTLTHRrfnYKDNTdLIEFKTL 258
Cdd:pfam00797 153 ----------LYSFTLEPRQIEDFEVGNDYLQTSPDSHFTTHLLCSRQTPDGRLTLTGRTLTLR---YKDGA-LVEIRLL 218
                         250       260
                  ....*....|....*....|..
gi 237649009  259 SEEEIEKVLKNIFNISLQRKLV 280
Cdd:pfam00797 219 TDEEVEDVLKERFGIELDAKLV 240
NhoA COG2162
Arylamine N-acetyltransferase [Secondary metabolites biosynthesis, transport and catabolism];
1-277 3.00e-79

Arylamine N-acetyltransferase [Secondary metabolites biosynthesis, transport and catabolism];


Pssm-ID: 441765  Cd Length: 256  Bit Score: 240.55  E-value: 3.00e-79
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009   1 MDIEAYLERIGYKKSRnKLDLETLTDILQHQIRAVPFENLNIHCGDAMDLGLEAIFDQVVRRNRGGWCLQVNHLLYWALT 80
Cdd:COG2162    3 FDLDAYLARIGYSGPP-APTLETLRALHRAHVRAIPFENLDVLLGRPISLDPDALFDKLVRRRRGGYCYELNGLFAALLE 81
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009  81 TIGFETTMLGGYVYSTPAKKYSTGMIHLLLQVTIDGRNYIVDAGFGrSYQMWQPLELISGKDQPQVPCVFRLTEE-NGFW 159
Cdd:COG2162   82 ALGFDVTLLAARVRWGGPGGPGPPRTHMALLVTLDGERWLVDVGFG-GGTPLEPLPLEDGTEQDQPGGTYRLVRSdDGEW 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009 160 YLDQIRREQYIPneeflhsdlledskyrkIYSFTLKPRTIEDFESMNTYLQTSPSSVFTSKSFCSLQTPDGVHCLVGFTL 239
Cdd:COG2162  161 VLQRRVDGGWRP-----------------LYRFDLEPQELADFEVANWYTSTHPDSPFVGNLLVARATPDGRVTLRGRRL 223
                        250       260       270
                 ....*....|....*....|....*....|....*...
gi 237649009 240 THRRfnykdNTDLIEFKTLSEEEIEKVLKNIFNISLQR 277
Cdd:COG2162  224 TRRR-----GGGEEERTLLSAEELAAVLRERFGLDLDD 256
PRK15047 PRK15047
N-hydroxyarylamine O-acetyltransferase; Provisional
3-284 9.43e-17

N-hydroxyarylamine O-acetyltransferase; Provisional


Pssm-ID: 185007  Cd Length: 281  Bit Score: 78.35  E-value: 9.43e-17
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009   3 IEAYLERIGYKKSrNKLDLETLTDI-LQHQIrAVPFENLNIHCGDAMDLGLEAIFDQVVRRNRGGWCLQVNHLLYWALTT 81
Cdd:PRK15047   5 LNAYFARINWSGA-AAVNIDTLRALhLKHNC-TIPFENLDVLLPREIQLDDQSLEEKLVIARRGGYCFEQNGLFERVLRE 82
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009  82 IGFET-TMLGGYVYSTPAKKysTGMIHLLLQVTIDGRNYIVDAGFGrSYQMWQPLELISGKDQPQVPCVFRLTEENGFWY 160
Cdd:PRK15047  83 LGFNVrSLLGRVVLSNPPAL--PPRTHRLLLVELEGEKWIADVGFG-GQTLTAPIRLVADIVQTTPHGEYRLLQEGDDWV 159
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009 161 LdqirreqyipneEFLHSDlledsKYRKIYSFTLKPRTIEDFESMNTYLQTSPSSVFTSKSFCSLQTPDGVHclvgFTLT 240
Cdd:PRK15047 160 L------------QFNHHQ-----HWQSMYRFDLCEQQQSDYVMGNFWSAHWPQSHFRHHLLMCRHLPDGGK----LTLT 218
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|....*
gi 237649009 241 HRRFNYKDNTDLIEFKTLSE-EEIEKVLKNIFNISLQRklvPKHG 284
Cdd:PRK15047 219 NFHFTHYENGHAVEQRNLPDvASLYAVMQEQFGLGVDD---AKHG 260
 
Name Accession Description Interval E-value
Acetyltransf_2 pfam00797
N-acetyltransferase; Arylamine N-acetyltransferase (NAT) is a cytosolic enzyme of ...
20-280 1.06e-125

N-acetyltransferase; Arylamine N-acetyltransferase (NAT) is a cytosolic enzyme of approximately 30kDa. It facilitates the transfer of an acetyl group from Acetyl Coenzyme A on to a wide range of arylamine, N-hydroxyarylamines and hydrazines. Acetylation of these compounds generally results in inactivation. NAT is found in many species from Mycobacteria (M. tuberculosis, M. smegmatis etc) to man. It was the first enzyme to be observed to have polymorphic activity amongst human individuals. NAT is responsible for the inactivation of Isoniazid (a drug used to treat Tuberculosis) in humans. The NAT protein has also been shown to be involved in the breakdown of folic acid.


Pssm-ID: 395644  Cd Length: 240  Bit Score: 357.74  E-value: 1.06e-125
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009   20 DLETLTDILQHQIRAVPFENLNIHCGDAMDLGLEAIFDQVVRRNRGGWCLQVNHLLYWALTTIGFETTMLGGYVYSTPAK 99
Cdd:pfam00797   1 DLETLRELHLHHLRAIPFENLDVHLGEPISLDLEALFDKLVHKRRGGYCYELNGLFYWVLTELGFDVTLLGGRVYWPRPG 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009  100 KYSTGMIHLLLQVTIDGRNYIVDAGFGRSYqMWQPLELISGKDQPQVPCVFRLTEENGF-WYLDQIRREQYIPneeflhs 178
Cdd:pfam00797  81 AYSTPQTHLLLLVTIDGETYLVDVGFGGST-LWAPLELISGKDQPTPHGIFRLVEEGGGtWYLEKDGRDGWVP------- 152
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009  179 dlledskyrkIYSFTLKPRTIEDFESMNTYLQTSPSSVFTSKSFCSLQTPDGVHCLVGFTLTHRrfnYKDNTdLIEFKTL 258
Cdd:pfam00797 153 ----------LYSFTLEPRQIEDFEVGNDYLQTSPDSHFTTHLLCSRQTPDGRLTLTGRTLTLR---YKDGA-LVEIRLL 218
                         250       260
                  ....*....|....*....|..
gi 237649009  259 SEEEIEKVLKNIFNISLQRKLV 280
Cdd:pfam00797 219 TDEEVEDVLKERFGIELDAKLV 240
NhoA COG2162
Arylamine N-acetyltransferase [Secondary metabolites biosynthesis, transport and catabolism];
1-277 3.00e-79

Arylamine N-acetyltransferase [Secondary metabolites biosynthesis, transport and catabolism];


Pssm-ID: 441765  Cd Length: 256  Bit Score: 240.55  E-value: 3.00e-79
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009   1 MDIEAYLERIGYKKSRnKLDLETLTDILQHQIRAVPFENLNIHCGDAMDLGLEAIFDQVVRRNRGGWCLQVNHLLYWALT 80
Cdd:COG2162    3 FDLDAYLARIGYSGPP-APTLETLRALHRAHVRAIPFENLDVLLGRPISLDPDALFDKLVRRRRGGYCYELNGLFAALLE 81
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009  81 TIGFETTMLGGYVYSTPAKKYSTGMIHLLLQVTIDGRNYIVDAGFGrSYQMWQPLELISGKDQPQVPCVFRLTEE-NGFW 159
Cdd:COG2162   82 ALGFDVTLLAARVRWGGPGGPGPPRTHMALLVTLDGERWLVDVGFG-GGTPLEPLPLEDGTEQDQPGGTYRLVRSdDGEW 160
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009 160 YLDQIRREQYIPneeflhsdlledskyrkIYSFTLKPRTIEDFESMNTYLQTSPSSVFTSKSFCSLQTPDGVHCLVGFTL 239
Cdd:COG2162  161 VLQRRVDGGWRP-----------------LYRFDLEPQELADFEVANWYTSTHPDSPFVGNLLVARATPDGRVTLRGRRL 223
                        250       260       270
                 ....*....|....*....|....*....|....*...
gi 237649009 240 THRRfnykdNTDLIEFKTLSEEEIEKVLKNIFNISLQR 277
Cdd:COG2162  224 TRRR-----GGGEEERTLLSAEELAAVLRERFGLDLDD 256
PRK15047 PRK15047
N-hydroxyarylamine O-acetyltransferase; Provisional
3-284 9.43e-17

N-hydroxyarylamine O-acetyltransferase; Provisional


Pssm-ID: 185007  Cd Length: 281  Bit Score: 78.35  E-value: 9.43e-17
                         10        20        30        40        50        60        70        80
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009   3 IEAYLERIGYKKSrNKLDLETLTDI-LQHQIrAVPFENLNIHCGDAMDLGLEAIFDQVVRRNRGGWCLQVNHLLYWALTT 81
Cdd:PRK15047   5 LNAYFARINWSGA-AAVNIDTLRALhLKHNC-TIPFENLDVLLPREIQLDDQSLEEKLVIARRGGYCFEQNGLFERVLRE 82
                         90       100       110       120       130       140       150       160
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009  82 IGFET-TMLGGYVYSTPAKKysTGMIHLLLQVTIDGRNYIVDAGFGrSYQMWQPLELISGKDQPQVPCVFRLTEENGFWY 160
Cdd:PRK15047  83 LGFNVrSLLGRVVLSNPPAL--PPRTHRLLLVELEGEKWIADVGFG-GQTLTAPIRLVADIVQTTPHGEYRLLQEGDDWV 159
                        170       180       190       200       210       220       230       240
                 ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 237649009 161 LdqirreqyipneEFLHSDlledsKYRKIYSFTLKPRTIEDFESMNTYLQTSPSSVFTSKSFCSLQTPDGVHclvgFTLT 240
Cdd:PRK15047 160 L------------QFNHHQ-----HWQSMYRFDLCEQQQSDYVMGNFWSAHWPQSHFRHHLLMCRHLPDGGK----LTLT 218
                        250       260       270       280
                 ....*....|....*....|....*....|....*....|....*
gi 237649009 241 HRRFNYKDNTDLIEFKTLSE-EEIEKVLKNIFNISLQRklvPKHG 284
Cdd:PRK15047 219 NFHFTHYENGHAVEQRNLPDvASLYAVMQEQFGLGVDD---AKHG 260
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH